The objective of this study is to elucidate the use of ultrasonography guided fine-needle aspiration biopsies (UG-FNAB) in the evaluation of thyroid nodules. The study population consisted of 790 UG-FNAB in 719 patients whom were admitted to the our endocrinology clinic. The cytological results were classified as benign, follicular lesion or suspicious for malignancy, malignant and non-diagnostic. The results of 790 UG-FNAB of 719 patients were as follows: 567 (71.77%) benign, 97 (12.28%) non-diagnostic cytology, 43 (5.44%) atypia with undetermined significance, 81 (10.25%) follicular lesion or suspicious for malignancy, 2 (0.25%) malignant. In our study, thyroid carcinoma rate was found to be lower than current literature. Of the malignant nodules which were reported as papillary thyroid carcinoma by UG-FNAB cytology, both were female, euthyroid and have single nodule in their thyroid gland. One of the patient (39 years old) had a micro nodule (< 1 cm in diameter) that it had an isoechoic pattern with regular margin on thyroid ultrasonography; whereas the other one (79 years old) had macro nodule (>1 cm diameter) that it had, hypoechoic pattern with irregular margin. None of them have calcifications in their nodules. Multidisciplinary approach including endocrinologists, radiologists and pathologists is essential for the management of patients with thyroid nodules to avoid missestimation of the risk of thyroid cancer.
Introduction
It was reported that 50% of the population have thyroid nodules verified by ultrasonographic examination [1] . Although thyroid nodular disease is common, especially among women, only a limited number of nodules are malignant. Thyroid cancer accounts for 1% of all malignancies [2, 3] . Ultrasound guided-fine needle aspiration biopsy (UG-FNAB) is the most preferred method in the evaluation of thyroid nodules. UG-FNAB has proven to be an important and widely accepted, cost-effective, simple, safe, and accurate method for triaging patients with thyroid nodules [4] . Approximately, 5% of nodules are malignant [5, 6] . UG-FNAB is effective for differentiating malignant thyroid nodules from benign.
The primary aim of this study was to elucidate the use of ultrasonography guided fine-needle aspiration biopsies (UG-FNAB) in the evaluation of thyroid nodules. The secondary aim was the compare ultrasonography features of the benign nodules with malign nodules.
Materials and Methods

Patients admitted to Outpatient Clinic of Endocrinology Department of Samsun Training and
Research Hospital with thyroid nodules from October 2011 to May 2013 (18 months) were included in the study. 790 UG-FNAB specimens from 719 patients were evaluated retrospectively.
Biopsy procedure: After physical examination, the patient was kept in the supine position with hyperextension of the neck with a rolled pillow. The nodule is localized with a 10 MHz transducer prior to biopsy. The overlying skin is cleansed with iodine. Local anesthetic, lidocaine sprey (Vemcaine® 10% pump sprey) was routinely administered to the neck region of the skin. Sampling was carried out using a fine needle (caliber 22 Gauge), manual aspiration and a 5-10 ml syringe. Once the needle was introduced into the solid part of the nodule, negative syringe pressure was applied. After aspiration, smear was placed on slides and air-dried. Two to three slides from each patient were stained with Wright-Giemsa stain to confirm the presence of follicular cells. The slides were subsequently stained with May-Grünwald-Giemsa stain.
Physical examination, UG-FNAB, and clinical follow-up of the patients were carried out by the same physician. Informed and signed consent were obtained from all patients. No serious complications were seen during the procedure. Postoperative histopathological examination of 60 thyroid glands specimens have showed that 51 (85%) of them had nodular goitre; whereas 3 (5%) of had follicular adenoma, and 6 (%15) of them had thyroid papillar carcinoma.
Demographic and nodular features of the patients were summarized at Table 1 . If we compared to ultrasonographic features of the benign and malign nodules proven by total thyroidectomy; no features were found to be significantly different between benign and malign nodules ( Table 1 ).
Morphological and clinical features of 60 patients who underwent total thyroidectomy were shown at Table 2 . The overall differentiated thyroid carcinoma ratio (confirmed by postoperative histopathological examination) was 0.84% for 719 patients. All of our nodules (n=6) which reported as "malignant" did not exceed 3 cm in diameter.
If we focuse on 6 thyroid papillar carcinoma cases which were detected after total thyroidectomy; 2 of them were already determined as "malignant" by UG-FNAB at first biopsy.
Four of them had a malignant tumor greater than 1 cm, whereas 2 of them were < 1cm. Patient who had micropapillar thyroid carcinoma was 49 years old male. He had multinodular goitre.
Tumor diameter was 0.8 cm and maximum nodule diameter was also 0.9 cm. And he had also had a follicular adenoma at another thyroid nodule < 1 cm at the other side of thyroid gland.
Similarly, 71 years old female had a tumor in one of her thyroid nodules, and also had a follicular adenoma at another thyroid nodule < 1 cm. Four of the papillar carsinoma cases were If we analyze the subgroup of 308 nodules which were equal or greater than 1 cm, number of thyroid carsinoma cases were 4 ( 1.3%). and familial history of thyroid malignancy [9, 11] . Recent literature indicates that patients with multiple thyroid nodules have the same risk of malignancy as patients with solitary thyroid nodules [12, 13] . Ultrasonographic characteristics are more reliable indicators of potential malignancy than nodule size [14] [15] [16] .
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On histopathological examination of various FNAB specimens, 5-20% of them are reported to be insufficient or non-diagnostic [17] [18] [19] [20] . Compatible with current data, in our study, nondiagnostic cytology were reported to be as 12.28%.
Instead of UG-FNAB, ultrasonographic monitoring is preferred in thyroid nodules which have diameter less than 5 mm, because of the difficulties to reach the nodule and the risk of obtaining inadequate material. In our study the nodules which surgery were performed with diameter of < 10 mm, and ≥ 5 mm, 2 micropapillar carcinoma was detected. On cytopathological examination of their FNAB, one of them was reported to be suspicious for malignancy, other was malignant.
None of them have any calcifications on their ultrasonographic examinations. Both of them also had a follicular adenoma at another thyroid nodule < 1 cm. (Table 3 ).
In our study, thyroid carcinoma rate was found to be lesser than in current literature. One of the reason for this may be higher ratio of nodules that underwent evaluation were lesser than 1 cm in diameters. But if we analyze the subgroup of the nodules equal to or greater than 1 cm, papillar carcinoma rate was still lesser (1.3%). There was no significance between the groups which have nodule < 1cm, and ≥ 1 cm (p>0.05). Our results may indicate that our region were associated with lesser papillar carcinoma rate. If we compere our results with some studies which were performed in our country, similar cytological malignancy rates could be seen [21] [22] [23] [24] . [24] . If we focuse on our malignancy results in nodules > 1 cm, this result is similar to ours. By being the one center which could perform UG-FNAB, other clinicians had been directed patients with thyroid nodule to our outpatient clinic. So, because of that, our indications for UG-FNAB might be higher than already needed. We thought that, thyroid cancer risk could be detected by using UG-FNAB even in thyroid nodules smaller than 1 cm, if the nodule has sonographically suspicious features for malignancy. So, it requires stronger collaboration between radiologist and endocrinologist. In conclusion, fine needle aspiration biopsy is a functional and reliable diagnosing method.
Using UG-FNAB leads to identify discrete nodules and direct needle localization and provides adequate specimen. UG-FNAB has become a predominant method for the diagnosis of benign and malign thyroid nodules. Atypical UG-FNAB results need to be considered in combination with clinical presentation, imaging data, and individual risk factors. Collaboration between endocrinologists, radiologists and pathologists is essential for patients with thyroid nodules to avoid missestimation of the risk of thyroid cancer.
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